Jennifer Swisher

Jennifer Swisher is a Supervisory Biologist in the Division of Product Quality Assessment XVI (DPQA16), Office of Product Quality Assessment III (OPQAIII) located in the Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER) at FDA. Biologics assessment staff in OPQA III are responsible for review of product quality information submitted in regulatory applications for therapeutic proteins, including new molecular entities and biosimilars. She joined the FDA 20 years ago as researcher-reviewer, also previously serving as a team lead for assessment biological products. Her scientific and regulatory interests are focused on antibody effector function and the safe administration of highly potent products.